Our results demonstrated that HJD treatment markedly alleviated colonic mucosal injury in UC mice, reduced the level of inflammatory cytokines (IL-1β, IL-6, and TNF-a) and MPO in colon, and increased the content of ATT. This evidence concerns the gene IL1B and spondyloepimetaphyseal dysplasia, Handigodu type.